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https://doi.org/10.1016/j.xpro.2020.100204SUMMARY
Galectins are soluble lectins that participate in many physiological and patholog-
ical functions. Since they can act extracellularly, the use of the recombinant
protein is a recurrent strategy for studying their biological functions. Here, we
provide a general protocol for the production of Galectins and their isolated or
chimeric domains. We take advantage of their lectin activity and the 6xHis-tag
addition for purification, thus obtaining a highly pure and active Galectin to
use in both in vitro and in vivo assays.
For complete details on the use and execution of this protocol, please refer to
Cattaneo et al. (2011), Tribulatti et al. (2012), and Prato et al. (2020).BEFORE YOU BEGIN
Cloning Galectin DNA Coding Sequence in an Expression Plasmid
Timing: n/a
1. Use the molecular biology technique of choice to clone the DNA sequence containing the open
reading frame encoding the Galectin of interest in an expression vector for bacteria with the
following characteristics:
a. N-terminal poly-histidine tag (6xHis)
b. Resistance to Ampicillin
c. IPTG-inducible expression using the regulatory sequences of a commercially available
plasmid.
For example, our designed optimized encoding sequence of human Gal-8 isoform M (hGal-8M) was
sent for synthesis to GenScript and then cloned in the pTrcHisB expression plasmid.
Note I: Galectin DNA codons should be optimized for expression in bacteria (this is already
included in the GenScript gene synthesis services).
Note II:We recommend propagating andmaintaining the plasmid encoding Galectin insert in
an adequate Escherichia coli strain such as TOP10 or DH5a.STAR Protocols 1, 100204, December 18, 2020 ª 2020 The Author(s).
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ProtocolObtaining Galectin-Expressing E. coli
Timing: 2 days
1. Transform by heat shock 100 ml of Cl2Ca-competent E. coli BL21 strain with 1 mg of the plasmid
containing Galectin insert. To this, incubate the mix of bacteria with DNA on ice for 20 min. Then,
place the bottom of the tube in a 42C water bath for 30 s, immediately followed by 2 min-incu-
bation on ice. Then, add 0.9 mL of LB and incubate for 1 h at 37C and shaking at 250 rpm. In
parallel, also transform bacteria with the empty plasmid as an expression control.
2. Grow transformed bacteria for 18–20 h at 37C in LB agar plates with Ampicillin.
3. Pilot expression:
a. Inoculate a single E. coli recombinant colony into 5 mL of terrific broth (TB) with Ampicillin in a
50 mL-conical tube.2
Optional: Screen several colonies to decide which clone has the maximal Galectin
expression.b. Grow for 18–20 h at 37C with shaking at 250 rpm.
c. Transfer 100 mL of 18–20 h culture to 5 mL of TB in a 50 mL-conical tube and reserve the
remaining culture at 4C.
d. Grow for 2 h at 37C with shaking at 250 rpm.
e. Add 1 mM IPTG and incubate for another 3 h at 37C with shaking at 250 rpm.Optional: Save 1 mL aliquot before IPTG addition, centrifuge, and conserve the pellet and
supernatant refrigerated or at 20C. This is an alternate expression control in case of do
not have the empty plasmid.f. Centrifuge 3 mL of the culture for 15 min at 14,000 rpm and 4C and discard the supernatant.
g. Resuspend the pellet in 200 mL of 13 PBS plus 2 mM EDTA and 1 mM PMSF.
h. Lyse the resuspended bacterial pellet by soaking the sonicator’s small horn/tip during 30 s and
setting the power at 15 watts.
i. Centrifuge for 10 min at 14,000 rpm and 4C.
j. Reserve the supernatant and resuspend the pellet in 200 mL of 8 M urea.
k. Run an aliquot from the resuspended pellet (5 mL), the supernatant (10 mL), and the LowMolecular
Weight (LMW)protein ladder (5mL) in10%SDS-PAGE.Stain thegelwithCoomassieblue,using the
protocol provided by the manufacturer, and verify the presence of a differential band of the ex-
pected size in the induced insert-containing clone. If different colonies were screened, decide
which clone has themajor expression of the recombinant protein in the soluble fraction (Figure 1).
Note: In the above-provided protocol, recombinant Galectins are purified from the soluble
fraction of bacterial lysate. In the pilot expression, however, the induced protein is usually ob-
tained in the insoluble fraction due to the particular induction conditions and does not neces-
sarily correlate with the scaled-up expression performed at 18C.
4. Glycerol stocks
a. Mix gently 500 mL of the reserved culture (point 2c) corresponding to the chosen clone (point
2k) with 500 mL of sterile glycerol.
b. Save immediately at 70C.
c. For each purification, inoculate and streak the bacteria from 70C glycerol stock on an LB
agar plate with Ampicillin.
Note: Galectin-transformed bacteria glycerol stocks can be stored for at least two years
at 70C. If after that period some differences of protein expression are experienced, a
new E. coli transformation should be accomplished.STAR Protocols 1, 100204, December 18, 2020
Figure 1. Analysis of Recombinant hGal-8 Pilot Expression by Coomassie Blue-Stained SDS-PAGE
A differential band of 36 kDa for Gal-8 M isoform (Gal-8M) and of 40 kDa for the L isoform (Gal-8L) can be observed on
insoluble fractions. pTrcHisB corresponds to bacteria transformed with the empty plasmid (negative control). SN,
supernatant. P, pellet. M, molecular weight marker.
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ProtocolGalectin Expression in E. coli
Timing: 3 days
5. Starter culture
a. Transfer a single colony of transformed bacteria (we used pTrcHisB-hGal-8M-transformed
E. coli BL-21 strain) to a sterile 50 mL-conical tube containing 5 mL of LB with Ampicillin.
b. Incubate for 18–20 h at 37C with shaking at 250 rpm.
6. Induction of protein expression
a. Expand the starter culture by dilution 1/100 into a sterile 2 L-baffled Erlenmeyer flask contain-
ing 500 mL of TB plus Ampicillin.
b. Incubate for 3–4 h at 37C with shaking at 250 rpm until OD600 nm= 1.
c. Low the temperature of the culture by refrigeration at 4C for 2–4 h.
d. Add 0.25 mM IPTG and incubate 18–20 h at 18C with shaking at 250 rpm.
Note: For Gal-3, 1 mM IPTG should be added instead for a proper expression induction. We
have observed for this particular Galectin that protein yield is very low when IPTG concentra-
tions are below 1 mM.
7. Cell collection
a. Centrifuge the culture for 15 min at 7,500 rpm and 4C.
b. Discard the supernatant and freeze the bacterial pellet at 70C.
Pause Point: Bacterial pellet can be stored at 70C for several months.STAR Protocols 1, 100204, December 18, 2020 3
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ProtocolKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Bacterial Strains
E. coli BL21 Merck Cat#GE27-1542-01




Lysozyme from chicken egg white Sigma-Aldrich Cat#L6876
Deoxyribonuclease I from bovine pancreas
(DNase)
Sigma-Aldrich Cat#D5025
D-Lactose monohydrate (Lactose) Sigma-Aldrich Cat#61339
Triton X-100 solution Sigma-Aldrich Cat#93443
PMSF Sigma-Aldrich Cat#P7626








Yeast extract Sigma-Aldrich Cat#Y1625
Ampicillin Sigma-Aldrich Cat#A8351
Terrific Broth, modified Sigma-Aldrich Cat#T0918
Glycerol Sigma-Aldrich Cat#G5150
NaOH Sigma-Aldrich Cat#S8045
Bovine serum albumin (BSA) Sigma-Aldrich Cat#05470
Glycerol (suitable for cell culture) Sigma-Aldrich Cat#G2025
Sodium azide Sigma-Aldrich Cat#71289






Coomassie Brilliant blue R Sigma-Aldrich Cat#B7920
Unstained SDS-PAGE standards, low range
(LMW)
Bio-Rad Cat#1610304
Acrylamide/Bis 19:1 Invitrogen Cat#AM9022
SDS Merck Cat#436143
TEMED Thermo Fisher Scientific Cat#17919
Ammonium persulfate Sigma-Aldrich Cat#A3678
Critical Commercial Assays
a-Lactose-Agarose Sigma-Aldrich Cat#L7634
(Continued on next page)
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Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
HisTrap Fast Flow GE-Healthcare Cat#GE17-5319-01
Pierce High Capacity Endotoxin Removal
Resin Thermo Fisher Scientific Cat#88272




Human Gal-8 M isoform GenBank NM_201543.3
Human Gal-8 L isoform GenBank NM_006499.4
Bovine Gal-8 GenBank NM_001045954.2
Mouse Gal-8S isoform GenBank AK004782.2
Mouse Gal-8 L isoform GenBank EF524570.1
Human Gal-3 GenBank NM_002306.4
Mouse Gal-3 GenBank NM_001145953.1
Human Gal-1 GenBank NM_002305.4
Mouse Gal-1 GenBank NM_008495.2
Recombinant DNA
pTrcHisB expression vector Thermo Fisher Scientific Cat#V36020
Other
0.45 mm syringe filters Corning Cat#431220
0.22 mm syringe filters Corning Cat#431219
Ice bucket Thomas Scientific n/a
2-mL bed Poly-Prep Chromatography
Columns
Bio-Rad Cat#7311550
Spectra/Por 6 Dialysis tubing, 3.5K MWCO,
18 mm, 33 ft
Thomas Scientific Cat#3787J84
Branson 450 analog sonifier Branson n/a
Ecotron thermostatic orbital shaker Infors HT n/a
Sorvall RC6 high-speed refrigerated
centrifuge
Thermo Fisher Scientific n/a
NanoDrop One spectrophotometer Thermo Fisher Scientific A38190
Peristaltic pumpa Cytiva, formerly GE Healthcare Life Sciences 18111091








Luria Bertani Broth (LB)
10 g/L tryptone,
5 g/L yeast extract,
5 g/L NaCl
Terrific Broth (TB)
47.6 g/L terrific broth,
8 mL/L glycerolSTAR Protocols 1, 100204, December 18, 2020 5
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ProtocolLB Agar Plate
Prepare LB agar containing Ampicillin in Petri dishes. The plates can be wrapped with film foil and
stored at 4C for up to 2 weeks.
Ampicillin
Prepare a stock solution of 100mg/mL in deionized water (1,0003 solution). Filter-sterilize through a
0.22 mm syringe filter. Store the stock solution in aliquots at 20C. To prepare media, add Ampi-
cillin to a final concentration of 100 mg/mL to the cooled broth.Buffers
Pyrogen-free PBS
Dissolve PBS powder following the manufacturer’s instructions using pyrogen-free water.Lysis Buffer
Reagent Final Concentration (mM) Amount (mL)
Phenylmethylsulfonyl fluoride (PMSF,
100 mM stock in isopropanol), add
immediately before use
1 0.3
Triton X-100 0.5% 0.3
13 PBS n/a 29.4
Total n/a 30
IMAC pH 8.8 Buffer (For Column Equilibrating and Washing)a
Reagent Final Concentration (mM) Amount (mL)
Tris buffer pH 8.8 (1 M) 20 0.4
NaCl (5 M) 50 2
Imidazole (1 M) 30 0.6
Pyrogen-free H2O n/a 17
Total n/a 20
IMAC pH 8.8 Buffer (For Column Seeding)a
Reagent Final Concentration (mM) Amount (mL)
Tris buffer pH 8.8 (1 M) 20 0.4
NaCl (5 M) 50 2
Imidazole (1 M) 30 0.6
Sample n/a n/a
Pyrogen-free H2O, to complete final 20 mL n/a n/a
Total n/a 20
IMAC pH 6.8 Buffera
Reagent Final Concentration (mM) Amount (mL)
Tris buffer pH 6.8 (1 M) 20 0.2
NaCl (5 M) 500 1
Imidazole (1 M, stock in Tris buffer pH 6.8
20 mM)
100 1
Pyrogen-free H2O n/a 7.8
Total n/a 10
aFresh new IMAC buffer must be prepared for each purification.
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TBS Saline Buffer
Reagent Final Concentration (mM) Amount
Tris-HCl pH 7.6 (1 M) 30 30 mL
NaCl (5 M) 500 100 mL
Pyrogen-free H2O n/a 920 mL
Total n/a 1 L
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Lactosyl-Sepharose
1. Before using:
a. On the first-time, pack 1 mL of resin into an empty 2 mL bed-column.
b. Before each use wash and equilibrate with 15 mL of PBS plus 1 mM PMSF.
2. After using:
a. Wash with 10 mL TBS saline buffer.
b. Store in TBS containing 0.1% sodium azide at 2C–8C.
HisTrap Fast Flow
1. Before using:
a. Wash the hose of the column with 50 mL of 1 M NaOH followed by 100 mL of pyrogen-free
water.
b. Check that pH is around 5.5 before connecting the hose to the column.
c. Wash the HisTrap column with 10 mL of pyrogen-free water.
d. Equilibrate with 5 mL of IMAC pH 8.8 buffer.
2. After using:
a. Wash with 15 mL TBS saline buffer.
b. Store in 20% ethanol at 2C–8C.
Pierce High-Capacity Endotoxin Removal
1. Before using:
a. On the first use, degas the resin slurry and pack 0.5 mL on an empty 2 mL bed-column.
b. Wash with 5 mL of pyrogen-free water.
c. Equilibrate with 5 mL of TBS saline buffer.
2. After using:
a. Regenerate the resin by incubating with 5 mL of 0.2 MNaOH during 18–20 h at 20C–24COR
5 mL of 0.2 M NaOH in 95% ethanol for 1–2 h at 20C–24C.
b. Wash with 5 mL of 2 M NaCl.
c. Wash with 5 mL of pyrogen-free water.
d. Store in 20% ethanol at 2C–8C.STEP-BY-STEP METHOD DETAILS
This protocol describes in detail the expression and purification of mouse Gal-8 L isoform. Different
Galectins and their derivatives that have been successfully purified using this method are listed in
Table 1, and the plasmids are available upon request. Comments and notes highlight differences
in the expression and/or purification steps between these Galectins and Gal-8. For any other given
Galectin, the provided methodology constitutes a useful base protocol in which additional modifi-
cations can be included in order to raise protein yieldSTAR Protocols 1, 100204, December 18, 2020 7
Table 1. List of Recombinant Galectins Successfully Purified by Following This Protocol
Galectin Reference Molecular Weight (kDa)
Human Gal-8 M isoform (Etulain et al., 2014) 36
Human Gal-8 L isoform (Etulain et al., 2014) 40.4
Human Gal-8N69 (Cattaneo et al., 2011) 36
Human Gal-8C233 (Cattaneo et al., 2011) 36
Mouse Gal-8 S isoform (Tribulatti et al., 2007) 36
Mouse Gal-8 L isoform (Tribulatti et al., 2007) 37
Mouse Gal-8 N-CRD (Romaniuk et al., 2010,
Cattaneo et al., 2011)
21
Mouse Gal-8 C-CRD (Romaniuk et al., 2010,
Cattaneo et al., 2011)
18
Mouse Gal-8 N-CRD-N-CRD (Romaniuk et al., 2010,
Cattaneo et al., 2011)
39.9
Mouse Gal-8 C-CRD-C-CRD (Romaniuk et al., 2010,
Cattaneo et al., 2011)
34
Bovine Gal-8 Unpublished 40.1
Human Gal-3 (Etulain et al., 2014) 30
Mouse Gal-3 (Tribulatti et al., 2012) 30
Human Gal-1 (Etulain et al., 2014) 14.5
Mouse Gal-1 (Tribulatti et al., 2012) 14.5
Mouse Gal-1-8-1 (Tribulatti et al., 2012) 34.2
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In this part of the protocol, bacteria cells are lysed, and the Galectin-containing extract is subjected
to two sequential steps of protein purification for a high purity yield. The first step consists of a
lactose-affinity chromatography, taking advantage of the Galectin’s specific lectin activity. Then,
the eluate is subjected to a Ni2+-affinity chromatography taking advantage of the His-tag presence
in the recombinant protein. Finally, imidazole is removed from protein preparation by dialysis, and
endotoxins are eliminated using a poly-L-lysine resin.
1. Cell Lysis
a. Unfreeze the pellet at 20C–24C until it starts to melt. Transfer immediately to ice.
CRITICAL: Maintain the sample and buffers on ice.
b. Resuspend the pellet in 30 mL of lysis buffer.
c. Add 100 mg/mL of lysozyme.
d. Wait until lysis is evident by observing an increased viscosity due to the release of DNA. Albeit
sufficient lysis can be observed immediately after pellet resuspension, it usually takes from 15
to 30 min, and occasionally, up to 1 h. Then add 10 mg/mL DNase.
CRITICAL: A complete lysis is required to obtain a high yield of recombinant protein.
e. Distribute the sample into two tubes and proceed to sonicate by soaking the sonicator’s small
horn/tip into the sample, setting the power at 15 watts. Perform five cycles of 30 s alternating
the tubes and maintaining on ice between each sonication cycle.8 STAR Protocols 1, 100204, December 18, 2020
Figure 2. Lactosyl-Sepharose Purification of Recombinant Mouse Gal-8 Isoform L (Gal-8L)
Aliquots from lactosyl-Sepharose-eluted fractions (1–7) were solved by 10% SDS-PAGE and stained with Coomassie
blue. Fractions 1–4 were pooled for subsequent IMAC purification. M, molecular weight marker.
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ProtocolAlternatives: In the absence of an ultrasonic cell disruptor, incubation with DNase should be
extended. Besides, the addition of Magnesium may be required in order to efficiently disrupt
the DNA.
f. Remove cell debris by centrifugation at 40,000 rpm for 45 min at 4C.
Alternatives: In the absence of an ultracentrifuge, cell debris can be removed by two consec-
utive centrifugation cycles at 20,000 rpm for 30 min at 4C.
g. Filter the supernatant through a 0.45 mm-pore membrane with a syringe.
2. Lactose-affinity chromatography
a. Seed the soluble filtered extract into a pre-equilibrated 1 mL Lactosyl-Sepharose column.
b. Wash the column with 20 mL of ice-cold PBS plus 1 mM PMSF.
c. Elute with 10 mL of ice-cold pyrogen-free PBS plus 1 mM PMSF and 100 mM lactose.
CRITICAL: Perform steps 2a to 2c by placing the column inside the refrigerator or in acooled room.d. Collect the elution in 1 mL-fractions.
e. Read the absorbance of each fraction at 280 nm using a nano-spectrophotometer to check the
presence of the recombinant protein. Troubleshooting 1
Alternatives: If a 280 nm spectrophotometer is not available, a Bradford reaction can be per-
formed to identify the elution peak.
Optional: Check purity and integrity of Gal-8 in a 10% SDS-PAGE (Figure 2). Use 15% SDS-
PAGE for Gal-1 and 12% SDS-PAGE for Gal-3.
Pause Point: Eluates can be stored up to 2 days on the refrigerator until IMAC purification.
3. Metal-affinity chromatography
CRITICAL: Keep all buffers and samples on ice. All buffers must be prepared with pyrogen-free water. If glass labware is used, it should be previously decontaminated at 180C for 3 h.STAR Protocols 1, 100204, December 18, 2020 9
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Protocola. Pool the protein-containing fractions and dilute 1/5 with IMAC pH 8.8 buffer (Example: 4mL of
the sample plus 16 mL of IMAC pH 8.8 buffer, please see buffer preparation).
b. Seed the sample into the pre-equilibrated HisTrap column at a 0.5 mL/min rate.
c. Wash the column with 15 mL of IMAC pH 8.8 buffer.
d. Elute the protein with IMAC pH 6.8 buffer, collecting fractions of 1 - 1.5 mL.
e. Read the absorbance at 280 nm in a nano-spectrophotometer using an aliquot of each fraction
to check for protein presence. Use the elution buffer as blank.
f. Dialyze during 18–20 h protein-containing fractions at a rate of 1/1000 (at least) in Tris-saline
buffer at 4C and mild agitation.
Alternatives: Bradford’s reaction can also be used to verify protein-containing fractions.
Alternatives: Dialysis can be performed in two consecutive steps using less buffer; for
example, two 1/250 dilutions.
Note: If biologically active Gal-1 is required, there is a need to prevent the formation of intra-
molecular disulfide bridges that hampers the correct homodimerization of this lectin, thus
leading to gGalectin activity loss (Guardia et al., 2014). This can be achieved by a protein alkyl-
ation reaction with iodoacetamide. As the dialysis step may not be sufficient to eliminate io-
doacetamide traces, it is recommended to perform this reaction between the purification
steps. To do this, invert steps 2 and 3 as follows: perform first steps 3b–3e, seeding the extract
into the pre-equilibrated IMAC column. Then, incubate the eluted protein for 18–20 h at 4C in
the presence of 0.1 M iodoacetamide. Next, dilute the alkylated lectin with PBS and executed
steps 2a–2e. To finish, dialyze the Gal-1-containing fractions and continue with step 4 of the
Protocol.
4. Endotoxin removal
a. Seed 1 mL containing 1–2 mg of the dialyzed Galectin into a 0.5 mL Pierce High-Capacity
Endotoxin removal resin.
b. Collect the pass-through and seed it again for four consecutive times.
c. Collect the final eluted protein.
d. Measure endotoxins with the technique/kit of choice to make sure all endotoxins were
removed. We use Endpoint Chromogenic LAL Assay. Endotoxin content is usually less than
0.06 UE/mL. Troubleshooting 2
Note: Poly-L-lysine can be regenerated five times after the first use.
Protein Preparation
Timing: 1 day
Recombinant protein purity and specific activity are checked in this part of the protocol. Also, proper
storage conditions to preserve Galectin integrity and function are described here.
5. Protein storage
a. Add 10% glycerol (suitable for cell culture) to stabilize the eluted protein and store up to
2 months at 4C. Troubleshooting 3
b. For longer time conservation, add 50% glycerol and store at 20C. Perform a hemagglutina-
tion assay (see step 7) to check the activity before its use.
6. Protein analysis
a. Determine protein concentration by measuring absorbance at 280 nm using a nano-spectro-
photometer.
b. Check purity and integrity of Gal-8 in a 10% SDS-PAGE.10 STAR Protocols 1, 100204, December 18, 2020
Figure 3. Step-by-Step Scheme of the Hemagglutination Assay
RBC, red blood cells. PBS-BSA: 13 PBS plus 1% BSA.
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ProtocolNote: Use 15% SDS-PAGE for Gal-1 and 12% SDS-PAGE for Gal-3.
7. Protein activity: hemagglutination assay (see scheme in Figure 3)
a. Add 1 mL of PBS to 100 ml of freshly obtained citrate-anticoagulated mouse blood and centri-
fuge at 3,500 rpm for 15 min at 4C.
b. Discard the supernatant and mix the pellet (40 mL approximately) with 960 ml of PBS plus 1%
BSA (PBS-BSA) thus obtaining a 4% v/v suspension of fresh mouse red blood cells (RBC).
c. Make two-fold serial dilutions of Gal-8 in PBS-BSA on a 96 well round-bottom plate, starting
with 144 to 1.125 mg/mL on a final volume of 50 mL. Use one well with PBS-BSA without Gal-8
as a hemagglutination negative control.
d. Carefully add 50 mL of RBC suspension to each well without mixing to avoid bubble formation
(just shake the plate by hand slightly at the end). Then, incubate the plate on a straight surface
for 1 h at 20C–24C without moving. Gal-8 activity is visualized by the presence of a homog-
enous RBC mesh covering the well vs. an RBC button.EXPECTED OUTCOMES
After Lactosyl-Sepharose purification, the elution peak is usually observed in fractions 2–3 and about
30 mg of total protein is obtained in those fractions.
After IMAC purification, the eluted protein is found mostly in fractions 3 and 4 and about 5–20 mg of
total protein is generally obtained in those fractions. Recombinant protein yields can vary among
different Galectins but are nearly always in the order of mg/mL. As an example, an SDS-PAGE res-
olution of IMAC Gal-8-eluted fractions is shown in Figure 4.
The expected hemagglutination activity for each Galectin and derivatives is depicted in Table 2.
Results from a hemagglutination assay using recombinant Gal-8 are shown in Figure 5 as an
example.LIMITATIONS
The present protocol was optimized for obtaining Galectin-8 and was successfully adapted for ob-
taining other Galectins such as Gal-1 and Gal-3 (Tribulatti et al., 2012). However, different conditions
for the expression and purification of other recombinant Galectins different from Gal-1, Gal-3, and
Gal-8, may be required and must be established in each case.STAR Protocols 1, 100204, December 18, 2020 11
Figure 4. IMAC Purification of Recombinant Mouse Gal-8 Isoform L (Gal-8L)
Aliquots from IMAC-eluted fractions (1–7) were solved by 10% SDS-PAGE and stained with Coomassie blue. Fractions
3 and 4 were pooled and dialyzed. M, molecular weight marker. W, wash. F, flow-through.
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Low yield of the recombinant Galectin after purification (expected yield is above 4 mg of protein).Potential Solution
1. Make sure that the lysis step is performed correctly. Do not add the DNase nor sonicate the
extract until the viscosity increases considerably. Wait as long as necessary and consider adding
extra lysozyme and placing the extract at 20C–24C (outside the ice bucket) for a short period.
2. Make sure that the columns are correctly regenerated and suitable for use. If necessary, recharge
the IMAC column with nickel following the manufacturer’s instructions. Prepare fresh IMAC
buffers from Tris 1 M stocks and check the pH.
3. Augment the concentration of IPTG to improve the induction of protein expression.Problem 2
Endotoxins are still present in protein preparation after the Poly-L-Lysine step.Table 2. Suggested Concentration Range to Perform Hemagglutination Assay for Different Galectins and the
Expected Activity
Galectin Recommended Dilution Range Expected Activity
Gal-8 144–1.125 mg/mL 18–4.5 mg/mL
Gal-3 40012.5 mg/mL 10050 mg/mL
Gal-1 100–3.12 mg/mL 25–12.5 mg/mL
Mouse Gal-8 N-CRD 168–10.5 mg/mL 42 mg/mL
Mouse Gal-8 C-CRD n/a None
Mouse Gal-8 N-N 40–0.625 mg/mL 5 mg/mL
Mouse Gal-8 C-C 72–1.125 mg/mL 18 mg/mL
Human Gal-8N69 72–0.56 mg/mL 9 mg/mL
Human Gal-8C233 288–18 mg/mL 72 mg/mL
Mouse Gal-1-8-1 50–1.56 mg/mL 6.25 mg/mL
12 STAR Protocols 1, 100204, December 18, 2020
Figure 5. Determination of the Hemagglutination Activity of Recombinant Mouse Gal-8 Isoform L (Gal-8L)
Hemagglutination assay using half-decreasing concentrations of Gal-8 (from 144 to 1.125 mg/mL). Red blood cell
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ProtocolPotential Solution
Regenerate the Poly-L-Lysine resin and repeat step 4, seeding the protein once again.
Be sure to use pyrogen-free solutions all along the purification process. Do not reuse plastic ware
and heat all glass labware before use. Carefully clean or replace the peristaltic pump tubing. It is
a good idea to reserve and save tubing for these assays if the peristaltic pump is used for other
purposes.
If the problem persists, consider using a new resin.Problem 3
WhenGalectin concentration is >5mg/mL, solubility may decrease during the storage at 4C, result-
ing in protein precipitation.Potential Solution
1. To avoid precipitation, maintain the protein in 0.5 M NaCl at a concentration below 5 mg/mL.
2. To clarify the protein solution, centrifuge at 15,000 rpm and 4C for 20 min. Then, determine the
protein new concentration and repeat the hemagglutination assay to check the lectin activity.RESOURCE AVAILABILITY
Lead Contact
Further information and requests for resources and reagents should be directed to and will be ful-
filled by the Lead Contact, Dr. Marı́a Virginia Tribulatti (vtribulatti@iib.unsam.edu.ar).Materials Availability
No new material was generated as part of this study.Data and Code Availability
No new code or data were generated as part of this study.ACKNOWLEDGMENTS
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